Search Within

Ravinder K Grewal

Formats
  1. Journal Article (55)
  2. Meeting Abstract (18)
  3. Book Section (4)
  4. Research Letter (2)
  5. Book Whole (1)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (82)
  2. Radiology, Department of (82)
  3. Department of Medicine (56)
  4. Survivorship Research (45)
  5. Division of Subspecialty Medicine (40)
  6. GSK Faculty (40)

More Groups

People
  1. Steven Larson (34)
  2. Robert Tuttle (28)
  3. Heiko Schoder (22)
  4. Alan Ho (16)
  5. James Fagin (15)
  6. Ronald Ghossein (12)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (5)

More Years

Publications
  1. Journal of Nuclear Medicine (11)
  2. Clinical Nuclear Medicine (7)
  3. Journal of Clinical Oncology (7)
  4. Thyroid (7)
  5. Blood (4)
  6. European Journal of Nuclear Medicine and Molecular Imaging (3)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Society of Nuclear Medicine (11)
  3. Lippincott Williams & Wilkins (10)
  4. American Society of Clinical Oncology (7)
  5. Mary Ann Liebert, Inc (7)
  6. Springer (7)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of salivary gland function after (177)Lu-PSMA radioligand therapy: Current concepts in imaging and management
    Review

    Mahajan, S.; Grewal, R. K.; Friedman, K. P.; Schòˆder, H.; Pandit-Taskar, N.
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to 177Lu-DOTATATE
    Meeting Abstract

    Coffman, K. L.; Bodei, L.; Le, T.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; Grewal, R. K.; Reddy, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Predicting malignancy in patients with adrenal tumors using (18)F-FDG-PET/CT SUVmax
    Journal Article

    Vos, E. L.; Grewal, R. K.; Russo, A. E.; Reidy-Lagunes, D.; Untch, B. R.; Gavane, S. C.; Boucai, L.; Geer, E.; Gopalan, A.; Chou, J. F.; more...
    Journal of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Interobserver agreement of (18)F-fluorodeoxyglucose positron-emission tomography combined with low-dose computed tomography for occult cancer screening in patients with unprovoked venous thromboembolism
    Research Letter

    Robin, P.; Grewal, R. K.; Le Roux, P. Y.; Le Gal, G.; Salaun, P. Y.
    Thrombosis Research (2020)

    Fulltext@MSK | Save
  • Pooled safety analysis of high-specific-activity I-131 MIBG in iobenguane scan positive cancer patients
    Meeting Abstract

    Jimenez, C.; Grewal, R. K.; Ravizzini, G.; Chin, B. B.; Pampaloni, M. H.; Matthay, K. K.; Jensen, J. D.; Lin, T.; Apfel, S.; White, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Thyroid cancer bone metastasis: Survival and genomic characteristics of a large tertiary care cohort
    Journal Article

    Kondraciuk, J. D.; Rice, S. L.; Zhou, X.; Gharzeddine, K.; Knezevic, A.; Spratt, D. E.; Sabra, M.; Larson, S. M.; Grewal, R. K.; Osborne, J. R.
    Clinical Nuclear Medicine (2019)

    Fulltext@MSK | Save